Mizuho Securities Downgrades Cubist Pharmaceuticals Post Acquisition Announcement

By: via Benzinga
Mizuho Securities downgraded Cubist Pharmaceuticals Inc (NASDAQ: CBST) Tuesday from Buy to Neutral and raised its price target from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.